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BACKGROUND
It is well accepted that the outcome and safety of a therapeutic intervention is often affected by patient-specific attributes, at the gene, cell and organ levels 1, 2 . It is also increasingly recognized that results from clinical trials do not necessarily apply to individual patients, not even to the patients that were directly enrolled in the trials 3 .
Every individual is shaped differently and the distribution, metabolism and elimination of drugs as well as their biochemical effects on the target cells are influenced by the patient age, genetic background and anatomical features. Computational modeling and nanomedicine are playing a major role in supporting the development of personalized therapeutic approaches [4] [5] [6] [7] [8] .
Computational modeling can capture the hierarchical complexity of biological systems and diseases over multiple scales -temporal and spatial -and include patient-specific information to personalize the outcome of the analysis. in silico modeling has been proven useful in orthopedic applications 9, 10 , for the treatment of cardiovascular diseases [11] [12] [13] [14] and cancer 15, 16 , and in pharmacogenomic analysis 6, 17 . Segmental bone replacements can be optimally designed after a careful analysis of patient anatomical features and computation of the mechanical loads 9 . In cardiovascular diseases, the authentic geometry of the blood vessels and their mechanical properties have been incorporated in sophisticated computational tools to predict the distribution of wall shear stresses, risk of aneurysm rupture and to optimize the deployment of vascular stents [18] [19] [20] .
Multi-physic models have been developed for predicting the response of tumors to molecular-based, radiation and thermal ablation therapies 15, 16 . Computational pharmacogenomics is used to predict in silico the efficacy, toxicity and possible resistance of drug molecules on different cell types 6, 16 .
On the other hand, a plethora of nanoparticle-based delivery systems have been developed over the last two decades for enhancing the tissue-specific accumulation of therapeutic molecules and the contrast generated by imaging agents. Indeed, the biodistribution and bioavailability of both therapeutic and imaging agents are dramatically affected by the size, shape, surface properties and mechanical stiffness (the 4Ss) of their carriers: the nanoparticles. This has been firstly predicted using mathematical models and then supported by experimental evidence, in vitro and in vivo [21] [22] [23] . Different fabrication strategies have been proposed to finely tune the geometrical, mechanical and surface properties of the nanoparticles [24] [25] [26] [27] . But how such four parameters (the 4Ss) can be rationally exploited in conjunction with patient-specific attributes to personalize and, thus optimize, therapeutic interventions is still largely unexplored.
Figure 1.
Reconstructing the patient-specific vascular geometry. The image shows, from left to right, the isocontour of a human heart, path extraction and editing of a small bifurcation portion from the left coronary artery (LCA) and reconstruction of the geometry ready for Isogeometric Analysis. Also, a nanoparticle with its ligand molecules is shown interacting with the receptor molecules decorating the surface of the endothelial cells in the vasculature.
Along this line, a patient-specific computational model is here presented for predicting the nanoparticle lodging within an authentic vascular network. Hexahedral solid NURBS (Non-Uniform Rational B-Splines) are used to accurately mesh the tridimensional architecture of an arterial tree, derived from the Computed Tomography (CT) scan of a patient 28 . The Finite Element Method (FEM), reformulated within the Isogeometric Analysis framework 29 , is employed to solve for the fluid and particle transport into the authentic vasculature 14 . Information at the micro and nanoscale are introduced in the computational model by developing a special boundary condition at the vessel wall, accounting for cell/nanoparticle adhesion 30 . The model directly integrates information from the macroscale (vessel geometry and permeability, blood flow condition) with data pertaining to the micro and nanoscale (particle geometry, receptor density and affinity), thus avoiding massive, computationally inefficient discretization over multiple spatial and temporal scales. The proposed in silico model is first validated against in vitro parallel plate flow chamber experiments and then is applied for studying the effect of patient-specific attributes, such as the vascular geometry and receptor surface density, on the deposition of particles with different geometrical and surface properties within an authentic arterial tree.
METHODS
Reconstructing the patient-specific vascular geometry. The input CT Angiography imaging data are often of poor quality due to large motions of the heart, as it supplies blood to the circulatory system. This makes it difficult to construct analysis-suitable patient-specific coronary models. To circumvent this problem, the raw imaging data were passed through a preprocessing pipeline where the image quality is improved by enhancing the contrast, filtering noise, classifying, and segmenting regions of interest 28 .
A small bifurcation portion of the coronary tree was considered here including the left coronary artery (LCA), the left anterior descending artery (LAD) and the left circumflex artery (LCX) (Figure 1 ). The surface model of this bifurcation structure was extracted from the processed imaging data, and the vessel path was obtained after skeletonizing the volume bounded by the local luminal surface using Voronoi and Delaunay diagrams. The generated path can also be edited according to simulation requirements, e.g., extending the included branch angles to study how geometry such as the bifurcation angle influences particle delivery processes in coronary arteries. A skeleton-based sweeping method 28 was then used to generate hexahedral control meshes by sweeping a templated quadrilateral mesh of a circle along the arterial path. A template for the bifurcation configuration was used to decompose the geometry into three mapped meshable patches using the extracted skeleton. Each patch can be meshed using one-to-one sweeping techniques. Some nodes in the control mesh lie on the surface, and some do not. We project nodes lying on the surface to the vascular surface. Finally, solid NURBS models were generated based on the constructed control meshes and they were employed in Isogeometric Analysis 31, 32 to simulate blood flow and particle delivery in the coronary arteries.
Governing equations for the fluid flow and particle transport. A continuum-based approach was adopted to simulate blood flow and particle transport within a patientspecific vascular network ( Figure 1 ). Blood was modeled as an incompressible
Newtonian fluid with a density (ρ) of 1060kg/m 3 and a dynamic viscosity (µ) of 0.003 Ns/m 2 , and the governing equations were formulated accordingly. Indeed, for sufficiently larger vessels (macrocirculation), the corpuscular component of blood (red blood cells, white blood cells and platelets) can be neglected and a Newtonian model for blood provides sufficiently accurate results 33, 34 . The strong form of the continuity and momentum balance equations in the fluid domain Ω with its boundary Γ divided into three non-overlapping parts, the inflow (Γ in ) and outflow (Γ out ) boundaries and the vascular wall (Γ s ), can be written as:
where x is a point in the spatial domain Ω and t is a point in the time domain [0,T]. In these equations, (x;t) represents the fluid velocity vector, p(x;t) the pressure, f the external body force, n the unit outward normal to the surface, denoted Γ, and (x;0) the initial velocity vector. An inflow velocity vector g(x;t) was specified at the inlet (Γ in ), a no-slip boundary condition (Eq. (4)) was prescribed at the rigid and impermeable vascular
wall (Γ s ) and a stress free outflow boundary condition (Eq. (5)) was implemented at the branch outlets (Γ out ).
The mass transport of the particles was assumed to be governed by a scalar advectiondiffusion-reaction equation. This is a reasonable assumption for sufficiently small particles navigating in large vessels 35, 36 . In the strong form, the transport problem can be stated as:
where (x;t) is the particle concentration, is the diffusivity tensor, and σ is the reaction coefficient. At the inlet (particle injection site) Γ in , a Dirichlet boundary condition is prescribed (Eq. (8)) where C 0 is the particle concentration given as:
Here t i denotes the duration of particle injection. At the outflow , a homogenous Neumann boundary condition was specified (Eq. (9)); and a Robin-type boundary condition (Eq. (10)), a combination of the Dirichlet and Neumann conditions, was prescribed at the rigid wall interface (Γ s ), where Π is defined in the sequel as the vascular deposition parameter.
Particle diffusivity was assumed to be isotropic and constant, and was determined from the Einstein-Stokes relation (13) as a function of the particle size, where d p is the diameter of the particles. Here represents the Boltzmann thermal energy. Then
where I is the 3×3 identity matrix. The velocity field u in Eq. (7) was obtained from the solution of the Navier-Stokes equations (Eqs. (1)- (6)) with the assumption that the flow physics affects the mass transport, not vice versa.
Boundary condition for particle adhesion to the vessel wall. The particle surface is assumed to be decorated with ligand molecules, uniformly distributed with a surface density m l , that can specifically interact with counter molecules (receptors) expressed on the vessel wall with a surface density m r (Figure 1 ). The molecular interaction between ligands and receptors is characterized by an affinity constant K a 0 , at zero mechanical load. From 30 , a probability of particle adhesion P a can be derived as a function of its geometry (size and shape) and surface properties (ligand density, ligand type; surface electrostatic charge). The mathematical parameter P a is defined as the probability of having at least one close ligand-receptor bond, and can be considered as a measurement of the strength of adhesion: the larger is P a , the larger is the avidity and strength with which the particle firmly adheres to the wall. For a spherical particle of diameter d p , the probability of adhesion can be expressed as follows 30 : (15) where is a characteristic length of the ligand-receptor bond, generally of the order of 0.1 -1 nm; is the Boltzmann thermal energy (= 4.142×10 -21 J); is the coefficient of hydrodynamic drag force on the spherical particle; is the wall shear stress; and S is the wall shear rate. In Eq. (15), the parameter r 0 is the radius of adhesion (16) with Δ the separation distance between the particle and the substrate, at equilibrium. An alternative representation of Eq. (15) is,
. (17), α 1 , α 2 , the wall shear rate S and the particle diameter d p are the independent governing parameters. For convenience, has been fixed to be 0.1 nm (see Table 1 ).
Parameters Value
Surface Drag coefficient on the spherical particle = 1.668 Table 1 . Adhesion model parameters used.
The mass flux of particles (∂C/∂n) in the direction n normal to the wall can be related to the local increase in mass of particles adhering per unit surface as (18) which simply derives from mass balance at the surface (accumulation of mass over time).
Note that Eq. (18) is not a boundary condition yet, in that is an unknown function.
To close the system, an additional relation needs to be defined between and . The number of particles per unit surface is in turn related to the volume concentration of particles at the wall through the equation
Note that Sd p /2 is the fluid velocity in the center of a particle in proximity of the wall.
The term Π = P a Sd p /2 is called the vascular deposition parameter, in that the larger is Π, the larger is the number of particle adhering stably to the vessel walls under flow.
In the Supplementary Materials, the system of governing equations (1)- (19) is specialized to the case of a channel with a rectangular cross section simulating a parallel plate flow chamber, used for the in vitro validation of the proposed computational approach. However, this maximum d p , as well as its absolute value, changes with the adhesive properties of both the particle and the substrate 30 . Indeed, this maximum identifies the threshold in particle diameter below (above), which adhesive interactions prevail (do not prevail) over the dislodging hydrodynamic forces. Such a biphasic behavior was already predicted for the general case of oblate spheroidal particles as well 30 Predicting particle transport and deposition in a patient-specific vascular network.
RESULTS

Predicting particle deposition in a parallel
The Isogeometric Analysis formulation was used to simulate the transport and wall adhesion of particles injected through a catheter in a patient-specific arterial tree. From the CT scan imaging data of a healthy volunteer, a hexahedral solid NURBS model for a portion of the left coronary artery (LCA) tree was generated following the steps described in 28 . The geometry of the problem is presented in Figure 3A . A time-dependent pulsatile inflow condition 37, 38 with a period of 1 s (heart rate = 60 beats per minute) was imposed at the LCA inlet, where also a cylindrical catheter was located through which particles were injected, both radially and axially at a speed of 4 cm/s, for 5 cardiac cycles (5 s).
The simulations were run on a computational mesh consisting of 55,100 quadratic NURBS elements for 14 cardiac cycles (14 s total) with a time step of 0.01 s employing the general solution strategies described in the Methods. Boundary layer meshes are used at the walls for more accurate computation of wall quantities, such as the wall shear rate.
The time evolution of the particle volumetric concentration within the vascular network is presented in Figures 3B-F . With time, the particle distribution front moves from the LCA inlet, where the catheter is located, toward the downstream branch and eventually into the side branches of the left anterior descending (LAD -left) and circumflex (LCX -right)
artery. At 1 s, the particle front has passed the bifurcation ( Figure 3C ); at 5 s, the particles are uniformly distributed within the vascular tree ( Figure 3D ); and at 14 s, they have left the LCX and LAD ( Figure 3F ). This distribution was obtained for the 0.5 µm particles.
In the sequel, the particle transport and wall deposition are analyzed as a function of the particle size and patient-specific attributes, such as the vascular geometry and the receptor surface density. In the lower branches (LAD and LCX), before and after injection, the wall shear rate is generally equal to or lower than ≈ 100 s -1 . Within this S range, the vascular deposition parameter Π for the 2 µm particles is, on the average, larger than that for the 0. It should also be noted that the injection flow rate from the catheter can significantly alter the wall shear rate distribution and thus affect the particle deposition rates and patterns.
Second, the branching angle between the LAD and LCX was increased from 76.8° to 106.8°, in the same patient-specific coronary geometry. As expected, the velocity magnitude and the wall shear rate distribution are significantly affected by such a change 44 . While the flow features appear similar in the LCA, the velocity magnitude and distribution become noticeably different as the branching point is approached, and moving downstream towards the two outlets (Supplementary Figure 5) . First, a larger recirculation area is seen at the branching. Second, due to the sharper bend encountered as the blood flows from the LCA to the LAD, a higher S zone appears at the LCA-LAD junction. Finally, the flow patterns in the LAD and LCX are different, introducing an asymmetry in the vascular tree. This difference is more noticeable in the post catheter injection period. As a consequence of the change in the S distribution, particles were observed to adhere more at the walls of the LAD rather than in the LCX. For both particle sizes, this is shown in Figure 5 and additional details are provided in Supplementary   Figure 6 .
Third, the contribution of the over-expression of receptor molecules on particle vascular deposition is investigated. For this, the surface density in the LAD is increased by a m r In the near future, the following scenarios can be envisioned where computational modeling and nanoparticle engineering would be intimately integrated. Currently, MRI and CT are the most easily accessible, minimally invasive systems for whole human body imaging and, in conjunction with ultrasonic measurements, can provide information on the three-dimensional architecture and velocity field in a patient-specific vasculature.
Nanoparticles can be engineered as potent MRI, or CT, contrast agents (imaging nanoconstructs) [45] [46] [47] [48] , molecularly targeted to a specific receptor family expressed over the diseased endothelial walls. This could be the integrin family on the tumor vasculature, inflammatory adhesion molecules in cardiovascular diseases and several others 49 . The number of adhering imaging nanoconstructs can be quantified by relating the contrast enhancement measured by the clinical scanner with the imaging properties of the single nanoconstruct. Knowing the number of adhering nanoparticles, the vascular geometry and mean hydrodynamic conditions, the computational model can be used to back Figure 6 . Nanoparticle adhesion to the vessel walls: effect of surface density of vascular receptors. The normalized surface density of 0.5 µm adhering nanoparticles is plotted along the arterial tree at various times t post injection: (A) t = 1 s, (B) t = 5 s and (C) t = 14 s. Data are presented for a uniform receptor density (m r = 10 9 #/cm 2 ) along the vasculature (left column) and for an LAD receptor density 10 times larger than that in the LCA and LCX (right column). Note that the color map scales are different for the two cases and give the particle number per unit area normalized by the injected dose [cm -2 ] .
calculate the mean receptor surface density following a reverse engineering approach.
This would be extremely useful for the in vivo rapid screening of potential vascular targets in individual patients 49 . With all this information at hand, the optimal particle configuration, in terms of size, shape, surface and stiffness can be identified using the computational models with the objective of maximizing drug release at the target site while minimizing non-specific sequestration in healthy tissue. Indeed, these scenarios are within reach but can only be achieved with an orchestrated development of potent, safe nanoparticle-based imaging tools and accurate, efficient computational methods. Here, Q is the flow rate per unit channel width with the velocity components , and in the , and z directions, respectively. Consequently, the wall shear rate S is uniform throughout the channel and has the form (S2)
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For the particle transport in the rectangular chamber, the governing equation Eq. (7) can be written explicitly as:
where is the particle isotropic diffusivity defined in Eq. (13) . Note that σ was set to zero in that no reaction occurs in the flow domain. Eq.(S3) is subjected to the following initial and boundary conditions. Particles were released into the fluid stream at the center of the inlet surface for a time period of t i = 30 seconds. Hence, at the inlet boundary, for t <t i (S4)
, and u x = u y = 0. three cases, the Péclet number was high (Pe >> 1000), making advection the dominant mode of particle transport rather than diffusion. To eliminate overshoot and undershoot near the inlet of the channel, the YZβ discontinuity capturing scheme 7 was employed. The coordinate z represents the distance from the inlet, along the channel length. ψ is quite uniform along the channel and independent of the longitudinal coordinate z. Although a slight nonuniform distribution is observed at the lower shear rate (S = 10 s -1 ), the ψ variation is still within 10%. Supplementary Figure 7 . Effect of the surface receptor density on particle adhesion. The surface concentration of 0.5 µm firmly adhering particles, normalized against the total number of particles injected [cm -2 ] , is shown at t = 14 s. Two cases are considered: uniform receptor density along the whole arterial three (left); and 10 times higher receptor density in the LAD as compared to the LCA and LCX (right). Note that the color map scales are different for the two cases. Insets highlight the surface particle concentration at the branch and within the recirculation zones.
